Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2/MCL-1 signaling axis. Luo Y, Fu Y, Kuang M, Wang J, et al. Br J Haematol 2025;207:46-58.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luo Y, Fu Y, Kuang M, Wang J, et al. Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2/MCL-1 signaling axis. Br J Haematol 2025;207:46-58.
PMID: 40328636